Scandion Oncology (Sweden) Price History
| SCOL Stock | SEK 0 0 38.81% |
If you're considering investing in Scandion Stock, it is important to understand the factors that can impact its price. As of today, the current price of Scandion Oncology stands at 0, as last reported on the 22nd of July, with the highest price reaching 0.01 and the lowest price hitting 0 during the day. Scandion Oncology owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0524, which indicates the firm had a -0.0524 % return per unit of risk over the last 3 months. Scandion Oncology AS exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Scandion Oncology's Variance of 183.69, risk adjusted performance of (0.01), and Coefficient Of Variation of (4,391) to confirm the risk estimate we provide.
Scandion Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Scandion |
Sharpe Ratio = -0.0524
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SCOL |
Estimated Market Risk
| 14.38 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.75 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Scandion Oncology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Scandion Oncology by adding Scandion Oncology to a well-diversified portfolio.
Scandion Oncology Stock Price History Chart
There are several ways to analyze Scandion Stock price data. The simplest method is using a basic Scandion candlestick price chart, which shows Scandion Oncology price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Scandion Stock Price History Data
The price series of Scandion Oncology for the period between Wed, Apr 23, 2025 and Tue, Jul 22, 2025 has a statistical range of 0.02 with a coefficient of variation of 36.96. The price distribution for the period has arithmetic mean of 0.01. The median price for the last 90 days is 0.01.| Open | High | Low | Close | Volume | ||
07/22/2025 | 0.01 | 0.01 | 0 | 0 | ||
07/11/2025 | 0.01 | 0.01 | 0 | 0 | 29,309,363 | |
07/10/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 56,832,002 | |
07/09/2025 | 0.01 | 0.02 | 0.01 | 0.01 | 68,404,395 | |
07/08/2025 | 0 | 0.02 | 0 | 0.01 | 92,405,448 | |
07/07/2025 | 0 | 0 | 0 | 0 | 4,509,418 | |
07/04/2025 | 0 | 0 | 0 | 0 | 543,040 | |
07/03/2025 | 0.01 | 0.01 | 0 | 0.01 | 2,555,052 | |
07/02/2025 | 0 | 0.01 | 0 | 0.01 | 17,008,946 | |
07/01/2025 | 0 | 0.01 | 0 | 0 | 7,067,286 | |
06/30/2025 | 0.01 | 0.01 | 0 | 0.01 | 1,285,875 | |
06/27/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 12,358,007 | |
06/26/2025 | 0.01 | 0.01 | 0 | 0.01 | 29,694,813 | |
06/25/2025 | 0.01 | 0.01 | 0 | 0.01 | 18,233,425 | |
06/24/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 421,389 | |
06/23/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 65,080 | |
06/19/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 886,214 | |
06/18/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 1,302,259 | |
06/17/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 2,072,283 | |
06/16/2025 | 0.01 | 0.02 | 0.01 | 0.02 | 6,221,677 | |
06/13/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 291,860 | |
06/12/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 1,094,568 | |
06/11/2025 | 0.02 | 0.02 | 0.01 | 0.01 | 6,545,181 | |
06/10/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 661,086 | |
06/09/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 1,407,849 | |
06/05/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 2,874,862 | |
06/04/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 818,458 | |
06/03/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 485,455 | |
06/02/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 1,272,661 | |
05/30/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 2,639,410 | |
05/28/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 913,184 | |
05/27/2025 | 0.02 | 0.02 | 0.01 | 0.02 | 3,566,627 | |
05/26/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 1,482,820 | |
05/23/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 753,981 | |
05/22/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 1,023,930 | |
05/21/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 5,970,727 | |
05/20/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 2,708,791 | |
05/19/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 3,275,223 | |
05/16/2025 | 0.02 | 0.02 | 0.02 | 0.02 | 7,426,317 | |
05/15/2025 | 0.03 | 0.03 | 0.02 | 0.02 | 5,048,699 | |
05/14/2025 | 0.02 | 0.03 | 0.02 | 0.03 | 15,067,945 | |
05/13/2025 | 0.02 | 0.02 | 0.01 | 0.02 | 3,742,415 | |
05/12/2025 | 0.02 | 0.02 | 0.01 | 0.02 | 4,073,631 | |
05/09/2025 | 0.02 | 0.02 | 0.01 | 0.02 | 2,716,168 | |
05/08/2025 | 0.02 | 0.02 | 0.01 | 0.02 | 2,248,184 | |
05/07/2025 | 0.02 | 0.02 | 0.01 | 0.02 | 1,060,230 | |
05/06/2025 | 0.02 | 0.02 | 0.01 | 0.02 | 9,294,930 | |
05/05/2025 | 0.02 | 0.02 | 0.01 | 0.01 | 3,488,085 | |
05/02/2025 | 0.02 | 0.02 | 0.01 | 0.01 | 1,190,145 | |
04/30/2025 | 0.01 | 0.02 | 0.01 | 0.01 | 2,488,951 | |
04/29/2025 | 0.01 | 0.02 | 0.01 | 0.01 | 11,421,365 | |
04/28/2025 | 0.01 | 0.02 | 0.01 | 0.01 | 19,069,665 | |
04/25/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 1,062,659 | |
04/24/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 180,784 | |
04/23/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 112,647 | |
04/22/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 2,625,848 | |
04/17/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 2,724,418 | |
04/16/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 1,962,527 | |
04/15/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 1,728,599 | |
04/14/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 1,642,537 | |
04/11/2025 | 0.01 | 0.02 | 0.01 | 0.01 | 12,460,324 |
About Scandion Oncology Stock history
Scandion Oncology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Scandion is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Scandion Oncology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Scandion Oncology stock prices may prove useful in developing a viable investing in Scandion Oncology
Scandion Oncology AS, a biotechnology company, develops drugs for the treatment of chemotherapy resistance in cancer patients. The company was founded in 2017 and is based in Copenhagen, Denmark. Scandion Oncology operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 6 people.
Scandion Oncology Stock Technical Analysis
Scandion Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
| All Next | Launch Module |
Scandion Oncology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Scandion Oncology's price direction in advance. Along with the technical and fundamental analysis of Scandion Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Scandion to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.48) | |||
| Total Risk Alpha | (2.85) | |||
| Treynor Ratio | (0.34) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Scandion Stock Analysis
When running Scandion Oncology's price analysis, check to measure Scandion Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scandion Oncology is operating at the current time. Most of Scandion Oncology's value examination focuses on studying past and present price action to predict the probability of Scandion Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scandion Oncology's price. Additionally, you may evaluate how the addition of Scandion Oncology to your portfolios can decrease your overall portfolio volatility.